Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Pfizer buys stake in French gene therapy firm Vivet

Pfizer acquired a 15 percent stake in Vivet Therapeutics as well as an exclusive option to fully acquire the business, a deal that will give the New York-based pharma giant access to the French company’s experimental gene therapy for a rare genetic disorder.

Read More »

Women’s History Month: Top Influential Women in Biopharma

March is National Women’s Month, and BioSpace recognized these 10 women as being especially influential in the biopharma industry.

Read More »

Alcon Acquires PowerVision for $285 Million

Alcon, the eye care division of Novartis, acquired fluid-based intraocular lens maker PowerVision Inc. for $285 million.

Read More »

U.S. court rejects Alvogen’s patent challenge for Celgene’s cancer drug

The U.S. patent office rejected a filing by Alvogen Pine Brook for a review challenging patents on Celgene’s blockbuster myeloma drug Revlimid.

Read More »

Novartis generics boss quits amid conjecture over business’s future

Novartis’ generics chief stepped down after the Swiss drugmaker sold parts of the business and initiated an 18-month revamp, fueling speculation about an eventual spin-off or sale.

Read More »

California jury awards $29 million to woman with cancer who used J&J talc

A California jury awarded $29 million to a woman who said abestos in Johnson & Johnson’s talcum-powder-based products caused her cancer.

Read More »

Companies lose bid to delay opioid epidemic trial

OxyContin manufacturer Purdue Pharma and two other drugmakers lost a bid to delay a landmark trial set for May 2019 in a multibillion-dollar lawsuit by Oklahoma’s attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state.

Read More »

Allergan depression treatment fails studies, shares slip

Allergan Plc’s experimental add-on treatment for depression failed three late-stage studies, casting doubts over the company’s drug pipeline and sending the Botox maker’s shares down nearly 4 percent.

Read More »

Fitbit launches lower-cost fitness devices to combat Samsung, Apple

Fitbit launched the company’s cheapest smartwatch to defend its position as the second-largest seller of smartwatches after Apple.

Read More »

French court dismisses damages claims against Merck

A court in the French city of Lyon threw out claims made by 4,113 plaintiffs for damages against Merck over changes to the company’s thyroid drug Levothyrox.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!

Subscribe

Ad Right Bottom